Relationship register · Company

Amicus Therapeutics

Amicus is a wholly owned subsidiary of BioMarin Pharmaceutical Inc., a leading, global rare disease biotechnology company focused on delivering medicines for people living with genetically defined conditions.

Also known as: Amicus, Amicus Therapeutics, Inc.
Official website: amicusrx.com
Relationship register: 1 documented relationship

Documented relationships

1 documented relationship

Hover or select an entity to isolate its relationships. Link thickness reflects the documented amount.

Detailed register

Muzammil MustufaEmploymentAmicus Therapeutics
Reported^{2Zura Bio Expands Leadership Team with Appointment of Muzammil Mustufa as Chief Business Officerfinance.yahoo.com}
Position or object indicated by the source: “Vice President of Corporate Strategy”.

Sources

1.
Home - Amicus Therapeutics | Advancing Therapies to Treat Rare Diseases
Web pageamicusrx.com
Institutional context: this homepage does not replace a specific source for a claim.
View original ↑ Back to text
2.
Zura Bio Expands Leadership Team with Appointment of Muzammil Mustufa as Chief Business Officer
Web pagefinance.yahoo.com
View original ↑ Back to text